CBS-001

N/A

Report date: 2023/01/18 20:00:35

Base Information

Drug NameCBS-001
Drug Alias NameCBS-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor superfamily member 14 inhibitors
TargetsTumor necrosis factor superfamily member 14
Therapy Area/IndicationsInflammationIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentessa Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesCentessa Pharmaceuticals Plc
Inactive CompaniesCapella Bioscience Ltd
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A